XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 353,834 $ 325,089
Investments 521,058 447,229
Accounts receivable, net 29,589 18,786
Inventory, net 61,955 50,381
Prepaid expenses and other current assets 14,375 10,289
Short-term restricted cash 300 300
Total current assets 981,111 852,074
Property and equipment, net 40,833 41,580
Operating lease right-of-use assets, net 38,247 39,763
Long-term restricted cash 2,922 2,922
Intangible assets, net 410,011 410,245
Goodwill 409,974 409,974
Other long-term assets 13,319 10,528
Total assets 1,896,417 1,767,086
Current liabilities    
Accounts payable 17,390 12,028
Accrued expenses 19,380 32,596
Deferred revenue, current 30,866 30,498
Operating lease liabilities, current 9,018 8,886
Other liabilities, current 4,670 7,233
Contingent consideration liability, current 184,350 172,094
Total current liabilities 265,674 263,335
Deferred revenue, non-current 1,849 1,794
Operating lease liabilities, non-current 38,969 41,070
Convertible senior notes, net, non-current 896,839 896,683
Other liabilities, non-current 969 1,300
Total liabilities 1,204,300 1,204,182
Commitments and contingencies
Stockholders’ equity    
Authorized 50,000 shares; No shares issued or outstanding 0 0
Authorized 1,000,000 shares; issued and outstanding 249,803 and 226,505 shares at March 31, 2023 and December 31, 2022, respectively 250 227
Additional paid-in capital 2,314,146 2,099,782
Accumulated other comprehensive loss (1,924) (4,765)
Accumulated deficit (1,620,355) (1,532,340)
Total stockholders’ equity 692,117 562,904
Total liabilities and stockholders’ equity $ 1,896,417 $ 1,767,086